The study to describe symptom control and impact on daily life in gastroesophageal reflux disease (GERD) patients

Study identifier:NIS-GBA-DUM-2010/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An epidemiological, observational study to describe symptom control and impact on daily life in patients with gastroesophageal reflux disease (GERD)

Medical condition

Gastroesophageal Reflux Disease

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

1233

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Sept 2010

Primary Completion Date: 01 Sept 2011

Study Completion Date: 01 Nov 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Apr 2012 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
1	-

Documents available

Trial Results Summaries
Available here

Contacts

Contact

Selma Sadovic

+387 33 295 413

[email protected]

Investigators

Principal Investigator

Srdjan Gornjakovic

Clinical Center University of Sarajevo; Department of Gastrenterology and HepatologySarajevo